BCV Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BCV Asset Management's LLY Position: Q2 2026 in Review
BCV Asset Management reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2026, selling an estimated $2.27M and leaving 80,697 shares worth $99.5M. The position accounts for 3% of the portfolio, ranked #8.
BCV Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $107M in Q4 2025. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- BCV Asset Management held 80,697 shares of Eli Lilly worth $99.5M as of Q2 2026.
- BCV Asset Management sold 2,226 Eli Lilly shares in Q2 2026, an estimated $2.27M.
- Eli Lilly made up 3% of BCV Asset Management's portfolio in Q2 2026, its #8 holding.
- BCV Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- BCV Asset Management's Eli Lilly position peaked at $107M in Q4 2025.
- 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on BCV Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.